New rabies vaccine shows promise in large trial
NCT ID NCT04127786
First seen Feb 13, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This Phase 3 trial tested a new rabies vaccine (VRVg-2) in 1708 healthy children and adults in Thailand. The goal was to see if it works as well as two existing rabies vaccines when given before exposure to the virus. Participants received a series of shots, and some got a booster dose later. The study is complete, and results will show if the new vaccine is a safe and effective option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 7640001
Bangkok, 10330, Thailand
-
Investigational Site Number : 7640002
Khon Kaen, 40002, Thailand
-
Investigational Site Number : 7640003
Bangkok, 10700, Thailand
-
Investigational Site Number : 7640004
Bangkok, 10400, Thailand
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Purified vero rabies vaccine - serum free (VRVg-2)
What this could lead to
If successful, this could provide a safe and effective alternative rabies vaccine for pre-exposure prevention in both children and adults.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The new vaccine must prove it is as good as existing ones, and rare side effects may still emerge.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.